K&P is advising BC Partners on the sale of Pharmathen
K&P is advising BC Partners on the sale of Pharmathen
Our firm is advising BC Partners on the sale of Pharmathen, a leading European pharmaceutical and drug delivery technology company, to global private markets firm Partners Group (acting on behalf of its clients). The transaction values the business at c. €1.6 billion.
The transaction is one of the largest ever in terms of selling value in the Greek market and is subject to the receipt of customary regulatory approvals, which are expected within 2021.
